388 related articles for article (PubMed ID: 12974897)
41. Shared genetic risk factors in autoimmune liver disease.
Czaja AJ; Santrach PJ; Breanndan Moore S
Dig Dis Sci; 2001 Jan; 46(1):140-7. PubMed ID: 11270778
[TBL] [Abstract][Full Text] [Related]
42. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases.
Burak KW; Urbanski SJ; Swain MG
Dig Dis Sci; 2001 Sep; 46(9):2043-7. PubMed ID: 11575461
[TBL] [Abstract][Full Text] [Related]
43. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.
Sherlock S
Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193
[TBL] [Abstract][Full Text] [Related]
44. Liver transplantation in autoimmune liver disease--selection of patients.
Tillmann HL; Jäckel E; Manns MP
Hepatogastroenterology; 1999; 46(30):3053-9. PubMed ID: 10626159
[TBL] [Abstract][Full Text] [Related]
45. The immunoreactive patient: Rejection and autoimmune disease.
O'Grady J
Liver Transpl; 2011 Nov; 17 Suppl 3():S29-33. PubMed ID: 21850694
[TBL] [Abstract][Full Text] [Related]
46. Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside.
Smyk DS; Bogdanos DP; Kriese S; Billinis C; Burroughs AK; Rigopoulou EI
Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):110-21. PubMed ID: 21907008
[TBL] [Abstract][Full Text] [Related]
47. Autoimmune liver diseases and antiphospholipid antibodies positivity: a meta-analysis of literature studies.
Ambrosino P; Lupoli R; Spadarella G; Tarantino P; Di Minno A; Tarantino L; Di Minno MN
J Gastrointestin Liver Dis; 2015 Mar; 24(1):25-34, 3 p following 34. PubMed ID: 25822431
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of autoimmune, cholestatic and nonalcoholic fatty liver disease in celiac disease.
Hitawala AA; Almomani A; Onwuzo S; Boustany A; Kumar P; Asaad I
Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):1030-1036. PubMed ID: 37395201
[TBL] [Abstract][Full Text] [Related]
49. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
[TBL] [Abstract][Full Text] [Related]
50. The Immunogenetics of Autoimmune Cholestasis.
Trivedi PJ; Hirschfield GM
Clin Liver Dis; 2016 Feb; 20(1):15-31. PubMed ID: 26593288
[TBL] [Abstract][Full Text] [Related]
51. Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists.
Trivedi PJ; Corpechot C; Pares A; Hirschfield GM
Hepatology; 2016 Feb; 63(2):644-59. PubMed ID: 26290473
[TBL] [Abstract][Full Text] [Related]
52. Familial association in autoimmune liver disease.
Findor JA; Sorda JA; Daruich JR; Manero EF
Medicina (B Aires); 2002; 62(3):241-4. PubMed ID: 12150007
[TBL] [Abstract][Full Text] [Related]
53. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.
Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R
Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease.
Moreira RK; Revetta F; Koehler E; Washington MK
World J Gastroenterol; 2010 Jan; 16(4):453-7. PubMed ID: 20101770
[TBL] [Abstract][Full Text] [Related]
55. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.
Terjung B; Spengler U
Clin Rev Allergy Immunol; 2005 Apr; 28(2):115-33. PubMed ID: 15879618
[TBL] [Abstract][Full Text] [Related]
56. Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms.
Marciano F; Savoia M; Vajro P
Dig Liver Dis; 2016 Feb; 48(2):112-9. PubMed ID: 26711682
[TBL] [Abstract][Full Text] [Related]
57. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.
Efe C; Wahlin S; Ozaslan E; Berlot AH; Purnak T; Muratori L; Quarneti C; Yüksel O; Thiéfin G; Muratori P
Eur J Gastroenterol Hepatol; 2012 May; 24(5):531-4. PubMed ID: 22465972
[TBL] [Abstract][Full Text] [Related]
58. [Autoimmune liver diseases].
Fischer HP; Goltz D
Pathologe; 2020 Sep; 41(5):444-456. PubMed ID: 32749523
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and clinicopathological Spectrum of Auto-Immune Liver Diseases & Overlap syndrome.
Varadarajan A; Rastogi A; Maiwall R; Bihari C; Thomas S; Sood V; Shasthry SM
Indian J Pathol Microbiol; 2024; 67(1):107-114. PubMed ID: 38358198
[TBL] [Abstract][Full Text] [Related]
60. Causal effect of autoimmune liver diseases on cancer: Meta-analyses of cohort studies and Mendelian randomization study.
Gu D; Zhang M; Wang Y; Bai Y; Wang X; Deng G
Liver Int; 2022 Oct; 42(10):2216-2226. PubMed ID: 35775855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
